Decreased platelet aggregation, Ca2+ and Mg2+ ATPase and platelet factor 3 activities in patients with Wilson disease.
D000293:Adolescent; D001779:Blood Coagulation Factors / Q000032:analysis*; D001792:Blood Platelets / Q000187:drug effects / Q000201:enzymology*; D017301:Ca(2+) Mg(2+)-ATPase; D000252:Calcium-Transporting ATPases / Q000032:analysis*; D002648:Child; D003300:Copper / Q000494:pharmacology; D005260:Female; D006527:Hepatolenticular Degeneration / Q000097:blood* / Q000235:genetics; D006801:Humans; D008297:Male; D010375:Pedigree; D010974:Platelet Aggregation; D010977:Platelet Factor 3 / Q000032:analysis*
D001779:Blood Coagulation Factors; D010977:Platelet Factor 3; D003300:Copper; D017301:Ca(2+) Mg(2+)-ATPase; D000252:Calcium-Transporting ATPases; C029892:cupric chloride